Journal of Inherited Metabolic Disease
@jimd-editors.bsky.social
1.1K followers 150 following 250 posts
The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). Social Media maintained by James Nurse
Posts Media Videos Starter Packs
Pinned
jimd-editors.bsky.social
Pharmacological chaperones for OTC deficiency, can small molecules stabilise urea-cycle enzymes and offer a new therapy?

Dr Alexander Laemmle joins me to discuss how iPSC-derived hepatocytes are bringing bench research closer to the clinic.

soundcloud.com/user-1090061...
jimd-editors.bsky.social
Allopurinol: not just for gout?
New JIMD paper shows improved cognition & adaptive skills in children with adenylosuccinate lyase deficiency after a year of treatment.
Younger patients benefitted most, linking metabolic correction to developmental gains.
doi.org/10.1002/jimd...
#ThinkMetabolic #ADSL
jimd-editors.bsky.social
Pharmacological chaperones for OTC deficiency, can small molecules stabilise urea-cycle enzymes and offer a new therapy?

Dr Alexander Laemmle joins me to discuss how iPSC-derived hepatocytes are bringing bench research closer to the clinic.

soundcloud.com/user-1090061...
jimd-editors.bsky.social
New: Priya Kishnani et al. revisit the genetics of hypophosphatasia — from inheritance patterns to the challenges of heterozygote disease and variant reclassification.
Essential update for anyone diagnosing or managing HPP.
#Hypophosphatasia #ThinkMetabolic

onlinelibrary.wiley.com/doi/10.1002/...
jimd-editors.bsky.social
Splenic artery aneurysm is a rare but dangerous complication of Gaucher disease.
🧬 Prevalence ~2.1% (2x higher than general population)
⚠️ Often linked to lack of ERT/SRT
💡 Routine splenic artery imaging may save lives
New study 👉 doi.org/10.1002/jmd2...
#Gaucher #RareDisease #JIMDReports
jimd-editors.bsky.social
Newborn screening saves lives in classic isovaleric aciduria.
📉 Mortality: 1.1% vs 10.9%
🧠 Developmental delay: 6.1% vs 51.2%
⚡ Earlier treatment start: 10 days vs 626 days
Meta-analysis of 240 cases across 23 countries.
👉 doi.org/10.1002/jimd...
#RareDisease #NewbornScreening
jimd-editors.bsky.social
Are #InheritedMetabolicDisorders more common than we think?
New review argues genotype-first data reveal IMDs in many “healthy” individuals — challenging assumptions about prevalence, penetrance & screening.
What should this mean for clinical care?
#ThinkMetabolic #Genomics
jimd-editors.bsky.social
🎧 50 years of newborn screening for galactosaemia in Ireland:

✅ Better survival
⚠️ Developmental challenges persist
Ina Knerr & Doireann Pereira share long-term insights in a new #JIMD Shortcast.

👉 soundcloud.com/user-1090061...

#NewbornScreening #RareDisease
jimd-editors.bsky.social
New in JIMD 📖 Study of 79 children with Gaucher disease shows some can be safely monitored without ERT, while others benefit in bone outcomes after therapy. WBLH BMD is key for monitoring.
Revel-Vilk et al., 2025
doi.org/10.1002/jimd...
#GaucherDisease #ERT #RareDisease
jimd-editors.bsky.social
🔹 Bluesky Post (shorter, to fit character limits)
New JIMD Podcast 🎙️ Nicole Smith, Olivia Garrett & Judy Fridovich-Keil discuss patterns of long-term outcomes in classic galactosemia, why complications vary, and why they cluster.
🎧 Listen: soundcloud.com/user-1090061...

#Galactosemia #RareDisease
jimd-editors.bsky.social
New: European practices in managing Tyrosinemia T1
Survey of 32 centers, 16 countries

Consistencies: NTBC + diet, AFP & ultrasound, transplant when needed

Variations: NTBC dosing, Tyr targets, Phe policies, follow-up

Clear need for harmonised European guidance.
👉 doi.org/10.1002/jimd...
jimd-editors.bsky.social
🎧 New #Researchroundup!

Raymond Wang (CHOC) joins Silvia & Rodrigo to dive into the latest in LSDs:
🔬 Base editing in Pompe
🧬 In vivo gene editing
🩸 Gaucher fibrosis score
🧪 Lipid dysregulation across LSDs
💉 Anakinra in Sanfilippo
open.spotify.com/episode/5cTN...
#RareDisease
jimd-editors.bsky.social
New in JIMD: 17 years of Dutch newborn screening with C5-OH + a global review of 58 studies.
➡️ PPV 38.3%, NPV 100%
➡️ Major overlap in affected/unaffected levels
➡️ Need for better markers/second-tier tests
Read here: doi.org/10.1002/jimd...
jimd-editors.bsky.social
Long-term follow-up (4–8 yrs) of olipudase alfa ERT in pediatric ASMD shows sustained improvements in organ size, lung function, growth & biochemistry. Safe, well tolerated, no discontinuations.

Open access JIMD
🔗 doi.org/10.1002/jimd...
#ASMD #OlipudaseAlfa #RareDisease
jimd-editors.bsky.social
Biomarkers are key to diagnosing NPC1, tracking progression and proving treatment effect in trials. A new review highlights their central role in regulatory approval and drug development.

📄 doi.org/10.1002/jimd...

#NPC1 #Biomarkers #RareDisease
jimd-editors.bsky.social
We talk with Detlev Boison about adenosine kinase, an ancient enzyme now seen as an epigenetic drug target. From epilepsy to cancer, could ADK open the door to disease-modifying therapy?

Spotify:
open.spotify.com/episode/1YRs...

Soundcloud:
soundcloud.com/user-1090061...
jimd-editors.bsky.social
🧠 New JIMD study: MRI in molybdenum cofactor deficiency shows a distinct pattern from HIE, with prognostic features & impact of cPMP therapy. Largest imaging series to date.
🔗 doi.org/10.1002/jimd...
jimd-editors.bsky.social
🌏✨ ICIEM 2025 is underway in Kyoto!

Not there? With no abstract book + little social media, it’s easy to miss great science.

👉 Sharing a poster/talk? Tag the Journal of Inherited Metabolic Disease and we’ll re-share to boost your reach.

#ICIEM2025 #ThinkMetabolic
jimd-editors.bsky.social
🎧 New #FootprintsOfIMD episode!
Eva Morava chats with Dakota Peacock & Darius Ebrahimi-Fakhari about movement disorders in IMD: from chorea to tremor, diagnosis to long-term care.

🎙️ Listen: open.spotify.com/episode/0xdF...
🔎 Search “JIMD Podcasts”

#IMD #neurogenetics
jimd-editors.bsky.social
A well neonate, an incidental X-ray finding, and a puzzle that sends the clinical team searching for answers.

Dr. Tolufase takes us step by step through this neonatal case of incidental adrenal calcifications.

🎧 Listen here: open.spotify.com/episode/3Lj1...

#ThinkMetabolic #RareDisease #IMD
jimd-editors.bsky.social
🧬 New review in JIMD:
Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic Diseases

Gurung et al outline key opportunities and hurdles in bringing mRNA therapy into clinical reality for monogenic liver disorders.

🔗 onlinelibrary.wiley.com/doi/10.1002/...
jimd-editors.bsky.social
🎙️ New JIMD Podcast!
Eva Morava & Irena Muffels are back to ask a massive question:
How do we treat all the CDGs?

Organoids, AI, basket trials & the three pillars shaping the therapeutic future of congenital disorders of glycosylation.
Listen now: soundcloud.com/user-1090061...

#CDG #RareDisease
jimd-editors.bsky.social
New data from the COMET trial:
Switching from alglucosidase alfa to avalglucosidase alfa improved respiratory outcomes in people with late-onset Pompe disease, especially those with worse baseline function.

Kishnani et al.
doi.org/10.1002/jmd2...
jimd-editors.bsky.social
New study suggests high-sensitivity troponin could be a useful early biomarker for cardiomyopathy in Fabry disease, aiding detection of cardiac involvement and guiding care.

“The Utility of hs-Troponin to Detect Cardiomyopathy in Fabry Disease” doi.org/10.1002/jmd2...
jimd-editors.bsky.social
2 registry studies, 2 different stories

Hughes – mostly treatment-naïve, older, milder phenotypes → stable kidney function, low event rates

Pisani – switched from long-term ERT, more classic males, more advanced disease → kidney decline, rising lyso-Gb3,

doi.org/10.1002/jimd...
jimd-editors.bsky.social
New #JIMDPodcast out now!
Sabine Fuchs and Eva Hoytema join us to explore the growing and complex world of aminoacyl-tRNA synthetase deficiencies, from diagnostic puzzles to multisystem phenotypes.

🎧 Listen wherever you get your podcasts
including Spotify: open.spotify.com/episode/4qpQ...